Ignite Creation Date:
2024-05-06 @ 8:00 PM
Last Modification Date:
2024-10-26 @ 3:18 PM
Study NCT ID:
NCT06213649
Status:
RECRUITING
Last Update Posted:
2024-01-22
First Post:
2024-01-09
Brief Title:
Parasitic Ulcer Treatment Trial
Sponsor:
Jeremy Keenan MD MPH
Organization:
University of California San Francisco
Study Overview
Official Title:
Parasitic Ulcer Treatment Trial
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PUTT
Brief Summary:
The Parasitic Ulcer Treatment Trial PUTT is a multi-center parallel-group randomized clinical trial The purpose of this study is to determine whether including topical corticosteroids in a regimen for acanthamoeba keratitis AK will improve vision Patients presenting to all enrollment centers with evidence of acanthamoeba keratitis will be eligible for the trial if there is evidence of ocular inflammation after 4 weeks of anti-amoebic therapy Those who agree to participate will be randomized to one of two treatment groups
Group 1 Topical corticosteroid
Group 2 Topical placebo
Group 1 Topical corticosteroid
Group 2 Topical placebo
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| UG1EY033284 | NIH | None | httpsreporternihgovquickSearchUG1EY033284 |